Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Fluticasone Propionate in Pediatric Atopic Dermatitis
NCT01915914Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray in atopic dermatitis (AD), sponsored by GSK. Started Dec 2013; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01915914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01915914.